US Patent Issued to Marius Pharmaceuticals on Sept. 2 for "Preferred oral testosterone undecanoate therapy to achieve testosterone replacement treatment" (North Carolina Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,403,146, issued on Sept. 2, was assigned to Marius Pharmaceuticals Inc. (Raleigh, N.C.).

"Preferred oral testosterone undecanoate therapy to achieve testosterone replacement treatment" was invented by Om Dhingra (Morrisville, N.C.) and James S. Bernstein (Raleigh, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention features new testosterone undecanoate (TU) dosing regimens, e.g., for testosterone replacement therapy. The TU may be formulated with phytosterols or phytosterol esters."

The patent was filed on Oct. 30, 2020, under Application No. 17/085,824.

*For further information, including images, charts and tables, please visit:...